Examples of HBV Program in a sentence
The objective of the HBV Program, as provided in the HBV Research Plan, shall be to utilize the Hookipa Technologies to Research Lymphocytic Choriomeningitis Virus- and Pichinde Virus-based vectors suitable for the Development, Manufacture, and Commercialization by Gilead, its Affiliates, or its sublicensees as HBV Licensed Products for the treatment, cure, diagnosis, or prevention of HBV.
Subject to Section 3(c) below, GSK shall be responsible, at its cost, for all further Manufacturing in relation to the HBV Program.
The Institution hereby acknowledges that both the Institution and the Researcher must take all administrative and technical measures required to ensure that the Data Set made available by the MNB under Point 1 of this Agreement is only used by the Institution and the Researcher for the research purpose stated in the Application Form and in Point 2 of this Agreement, and that the Data Set does not come to the knowledge of unauthorized third parties.
The following revised financial provisions will apply solely to the HBV Program: a.
For avoidance of doubt, except as expressly amended by this Amendment No. 7, the terms and conditions of Section 5.6.2 of the Agreement continue to apply to the HBV Program with respect to Compounds that are not the HBV Lead Compound or the HBV LICA DC.
Except as expressly set forth in Section 5.6.2 of the Agreement (as Section 5.6.2 of the Agreement relates to Compounds that are not the HBV Lead Compound or the HBV LICA DC), each milestone set forth in Table 3B above will be paid only once for the HBV Program upon the first achievement of the Milestone Event, regardless of the number of Licensed Compounds, Follow-On Compounds or Licensed Products resulting under the HBV Program.
The objective of the HBV Program, as provided in the HBV Research Plan established under the Original Collaboration Agreement, was and is to utilize the Hookipa Technologies to Research Lymphocytic Choriomeningitis Virus- and Pichinde Virus-based vectors suitable for the Development, Manufacture, and Commercialization by Gilead, its Affiliates, or its sublicensees as HBV Licensed Products for the treatment, cure, diagnosis, or prevention of HBV.
In addition, GSK will provide Ionis with [***] and [***] regarding adverse events and material lab findings under any Clinical Study for the HBV Lead Compound being conducted on behalf of GSK prior to the date of exercise of its Option to the HBV Program.
Upon Alnylam HBV Program Completion, subject to the exercise by Alnylam of its Profit-Sharing Option pursuant to Section 4.2 with respect to an HBV Licensed Product and Alnylam’s responsibilities for HBV Licensed Product Manufacturing at Vir’s expense pursuant to Article V, Vir shall assume all responsibility for the further Development, Manufacture and Commercialization of HBV Licensed Products.
NOTWITHSTANDING THE FACT THAT GSK HAS NOT EXERCISED ITS OPTION FOR THE HBV PROGRAM, GSK WILL PROVIDE IONIS THE COOPERATION AND INFORMATION DESCRIBED IN SECTION 4.4.1 OF THE AGREEMENT AS IT RELATES TO ACTIVITIES UNDERTAKEN BY GSK IN RELATION TO THE HBV LEAD Compound prior to the date of exercise of its Option to the HBV Program.